Mary Beth Nierengarten is a writer, editor and journalist with over 25 years of medical communications experience. She is a regular contributor to a number of online and print publications and writes in most clinical areas, as well as on health policy and economic issues. She lives in Minneapolis and can be reached at [email protected].
Recent updates to criteria used for diagnosing neuromyelitis optica (NMO) are aimed at helping physicians make the differential diagnosis of this disorder differentiating it from other inflammatory disorders—a diagnosis that can be difficult given the presenting symptoms that can mimic a number of other conditions, such as multiple sclerosis. Published in July 2015, the new…
Physician burnout is high and climbing. A 2015 report published by Medscape showed that nearly half (46%) of physicians surveyed responded that they were experiencing burnout; that number is up from 39.8% reported in a similar survey in 2013.1 These physicians experience the tell-tale signs of burnout: loss of enthusiasm for work (or emotional exhaustion),…
In diagnosing and treating a disease that is rapidly gaining recognition worldwide since it was first recognized in Japan in 2003, 42 experts from 10 different countries recently collaborated to discuss and review the current experience and data on IgG4-related disease. The result is the “International Consensus Guidance Statement on the Management and Treatment of…
For patients living with a chronic disease, such as rheumatoid arthritis or osteoarthritis, learning to manage and cope with the myriad adverse symptoms that accompany these diseases is key to improving quality of life and helping reduce the cost burden of these illnesses on the healthcare system. One important way rheumatologists can help is by…
The pathogenesis of and new classification criteria for MAS
Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA
Experts highlight research on the overlap in innate and acquired immune responses underlying rheumatic diseases
Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
Clinical manifestations, approaches to diagnosis, treatment